The United States (US) highly values the individual and societal benefits of vaccination and invests significantly in vaccine development and use as part of its national vaccine enterprise. In 1986, recognizing the small, but non-zero risks associated with vaccines, the US created a mechanism to collect excise taxes on each dose of vaccine to fund a national Vaccine Injury Compensation Program (VICP). The VICP includes a system for those claiming serious injuries from vaccines to seek compensation, and a process to pay individuals with legitimate claims and their legal counsel. Given the maturity of the VICP, we review experience with the vaccines and injuries covered, claims, and economics of the fund. Our review shows the excellent safety track record of vaccines, provides some evidence of injuries related specifically to vaccine delivery, and discusses the financial health of the fund.

中文翻译：

---

美国疫苗伤害赔偿计划（VICP）的绩效：1988-2019。

美国（美国）高度重视疫苗接种的个人和社会利益，并作为其国家疫苗企业的一部分，大力投资疫苗的开发和使用。1986年，美国意识到与疫苗相关的微小但非零风险，因此创立了一种机制，对每剂疫苗征收消费税，以资助国家疫苗伤害补偿计划（VICP）。VICP包括针对那些因疫苗造成严重伤害的人寻求赔偿的系统，以及向有合法主张的人及其法律顾问付款的程序。鉴于VICP的成熟度，我们将回顾疫苗的经验以及所涵盖的伤害，索赔和基金的经济性。我们的审查显示了出色的疫苗安全记录，提供了一些与疫苗接种相关的伤害证据，